TAM in HL, determined both by GEP and by IHC using the markers CD68, emerged as a relevant prognostic factor of disease-specific survival and PFS in the pivotal paper by Steidl and colleagues, outperforming the international prognostic score (IPS) [115]. Here, CD68 is linked to Hodgkins lymphoma.